Skip to main content

Metabolites as immunomodulatory additives for biomaterials

Project description

Immunomodulatory metabolites in biomaterials

Biomaterials are crucial for the surgical correction of bone defects caused by diseases and traumatic fractures. Risks associated with this treatment include inflammation and bone infection, and the host immune response to implanted materials represents the main factor determining the long-term outcome of the treatment. Bioactive metabolites have emerged as one of the most innovative and potent approaches for immune response modulation. The incorporation of metabolites with immune regulatory properties is an especially attractive option for biomaterials, ensuring a site-specific delivery system and the modulation of the microenvironment. The goal of the EU-funded Met4Bone project is to develop novel biomaterials with incorporated metabolites as an effective strategy to modulate local immune response, leading to favourable outcomes of surgical bone remediation.

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

RIGAS TEHNISKA UNIVERSITATE
Address
Kalku Iela 1
1658 Riga
Latvia
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 152 202,24